Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSN-013 (estetrol/drospirenone) in Japanese endometriosis patients
jRCT2080225090Phase 2Completed
- Sponsor
- Fuji Pharma Co., Ltd.
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of estetrol in endometriosis (2 arms), sponsored by Fuji Pharma Co., Ltd. Primary endpoints: Pharmacodynamics of FSN-013, Pharmacokinetics of FSN-013 and 1 more. Started Feb 2020; status: completed.
02
Drugs
estetrol
03
Conditions
endometriosis
Beyond the preview
Go deeper on jRCT2080225090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225090.